Literature DB >> 27513798

Outcomes of regional transfers of ruptured abdominal aortic aneurysm in a UK vascular network.

V K Proctor1, M J Lee2, A H Nassef1.   

Abstract

INTRODUCTION Rupture of abdominal aortic aneurysm is a surgical emergency. In order to improve operative outcomes, vascular services have been centralised in the United Kingdom. This means that a patient may present to a hospital with a ruptured aneurysm, but require transfer to a vascular centre for definitive treatment. METHODS This retrospective cohort study identified patients who underwent surgery for ruptured abdominal aortic aneurysm in a tertiary vascular centre over a 2-year period. Data on demographics and originating unit were recorded. Outcomes assessed included 30-day mortality, operative mortality and postoperative morbidity. RESULTS We identified 70 patients who underwent surgery for ruptured abdominal aortic aneurysm in the 2-year period; 36 presented directly to the vascular unit (VU), 14 to referral unit 1 (RU1) and 20 to referral unit 2 (RU2); 30-day mortality rates were 27.7% (VU), 35.5% (RU1) and 30.0% (RU2), respectively. There was no statistical difference in mortality between units. Postoperative complications were seen in 35.9% of VU patients, 78.6% of RU1 patients and 70% of RU2 patients. This was statistically significant between VU and RU1 (P = 0.006) and VU and RU2 (P = 0.02). Direct operative complications were seen in 9 patients, gastrointestinal complications in 9, limb complications in 6 and systemic complications in 40. CONCLUSION This study found that site of presentation does not affect mortality but is associated with increased morbidity. This is a complex issue, which will require a prospective multicentre study to investigate further.

Entities:  

Keywords:  Abdominal aortic aneurysm; Complications; Ruptured aneurysm; Transfer

Mesh:

Year:  2016        PMID: 27513798      PMCID: PMC5392785          DOI: 10.1308/rcsann.2016.0231

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN: 0035-8843            Impact factor:   1.891


  7 in total

1.  Interfacility transfer and mortality for patients with ruptured abdominal aortic aneurysm.

Authors:  Matthew W Mell; Nancy E Wang; Doug E Morrison; Tina Hernandez-Boussard
Journal:  J Vasc Surg       Date:  2014-04-24       Impact factor: 4.268

2.  Resource utilization and outcomes: effect of transfer on patients with ruptured abdominal aortic aneurysms.

Authors:  Todd R Vogel; Gary B Nackman; Lucy S Brevetti; J G Crowley; Maureen M Bueno; Adrienne Banavage; Karen Odroniec; Rocco G Ciocca; Alan M Graham
Journal:  Ann Vasc Surg       Date:  2005-03       Impact factor: 1.466

3.  Early detection of major complications after abdominal aortic surgery: predictive value of sigmoid colon and gastric intramucosal pH monitoring.

Authors:  M Björck; B Hedberg
Journal:  Br J Surg       Date:  1994-01       Impact factor: 6.939

4.  pHi monitoring of the sigmoid colon after aortoiliac surgery. A five-year prospective study.

Authors:  M Björck; F Lindberg; G Broman; D Bergqvist
Journal:  Eur J Vasc Endovasc Surg       Date:  2000-09       Impact factor: 7.069

5.  Risk factors for predicting postoperative complications after open infrarenal abdominal aortic aneurysm repair: results from a single vascular center in China.

Authors:  Cai Li; Wen-Han Yang; Jun Zhou; Yan Wu; Yun-Sheng Li; Shi-Hong Wen; Wen-Qi Huang; Ke-Xuan Liu
Journal:  J Clin Anesth       Date:  2013-08-17       Impact factor: 9.452

6.  Effect of the duration of symptoms, transport time, and length of emergency room stay on morbidity and mortality in patients with ruptured abdominal aortic aneurysms.

Authors:  M M Farooq; J A Freischlag; G R Seabrook; M R Moon; C Aprahamian; J B Towne
Journal:  Surgery       Date:  1996-01       Impact factor: 3.982

7.  Observations from the IMPROVE trial concerning the clinical care of patients with ruptured abdominal aortic aneurysm.

Authors:  J T Powell; R J Hinchliffe; M M Thompson; M J Sweeting; R Ashleigh; R Bell; M Gomes; R M Greenhalgh; R J Grieve; F Heatley; S G Thompson; P Ulug
Journal:  Br J Surg       Date:  2014-02       Impact factor: 6.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.